Back

Flecainide to prevent atrial arrhythmia after patent foramen ovale closure, the AFLOAT randomized study

2 September 2024 (15:15 - 15:27)
Organised by: Logo
Congress Presentation Part of: Smaller trials, trial updates, and other studies on atrial fibrillation Patent Foramen Ovale (PFO) / Atrial Septal Defect (ASD) Closure ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Professor Gilles Montalescot

Pitie Salpetriere APHP University Hospital, Paris (France)

4 More presentations in this session

Presentation thumbnail
Enhanced Detection and Quickened Diagnosis of Atrial Fibrillation Using Apple Watch: A Randomized Controlled Trial
Doctor M. Winter (Amsterdam, NL)
Slides Video
Presentation thumbnail
Detection of silent atrial fibrillation in high stroke risk patients using bed sensor and smartphone app: the CARE-DETECT trial
Doctor J. Lehto (Turku, FI)
Slides Video
Presentation thumbnail
Atrial fibrillation follow-up investigation to recover memory and learning trial
Doctor X. Du (Beijing, CN)
Slides Video
Presentation thumbnail
Manual chest PRESSURE during direct current cardioversion for Atrial Fibrillation: a randomized control trial (PRESSURE-AF).
Doctor D. Ferreira (Newcastle, AU)
Slides Video

Access the full session

Session thumbnail
Smaller trials, trial updates, and other studies on atrial fibrillation
Video

The Event

Event poster

ESC Congress 2024

2 September 2024 15:15 CET
You may be interested in
thumbnail
Congress Session
Smaller trials, trial updates, and other studies on atrial fibrillation
thumbnail
Congress Session
Practical dilemmas in atrial fibrillation therapies
thumbnail
Congress Session
Scanning the horizon: trials that will improve care of atrial fibrillation patients

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources